Bayer Baycol Label Revised To Emphasize Risk Of Starting With .8 mg Dose
Executive Summary
Bayer is revising labeling for its cholesterol-lowering agent Baycol to emphasize the need to use a .4 mg starting dose.
You may also be interested in...
Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?
Bristol-Myers Squibb's Pravachol is gaining share in the retail market in the early days following the withdrawal of Bayer's Baycol, prescription tracking data from ArcLight indicate.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011